Biosimilar erythropoiesis-stimulating agents and the risk of developing anti-drug antibodies—a systematic review
Crossref DOI link: https://doi.org/10.1007/s00228-016-2096-z
Published Online: 2016-07-21
Published Print: 2016-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Arnlind, Marianne Heibert
Fryklund, Linda
Vitols, Sigurd
Bertilsson, Göran https://orcid.org/0000-0002-5660-7376
License valid from 2016-07-21